Nr546 antidepressants - Study guides, Class notes & Summaries

VERIFIED QUESTIONS AND ANSWERS FOR NR546 Pharmacologic Treatment of Major Depressive Disorder - CORRECT ANSWERSelective serotonin reuptake inhibitors (SSRIs) Serotonin-norepinephrine reuptake inhibitors (SNRIs) Norepinephrine and dopamine reuptake inhibitors (NDRIs) Serotonin antagonists and reuptake inhibitors (SARIs) Miscellaneous antidepressants Monoamine oxidase (MAO)-B inhibitors Adjunct: antipsychotics Pharmacologic Treatment of Bipolar Disorder - CORRECT ANSWER-Lithium Anticon...

NR546 Midterm Exam Are the PMHNP and other staff liable if the client has an allergic reaction or adverse side effects to the drugs used for chemical restraint? - Answer-No. The client has been court-ordered to take the prescribed medications and the standing order for chemical restraints is approved. The PMHNP and other staff are not liable if the patient has an allergic reaction or adverse side effects. How does reviewing the genetic makeup of a client help guide the PMHNP in selec...

NR546 Antidepressant and Mood Stabilizer Medication Table. Antidepressant Medications Name Indication, starting dose, target symptoms, and affected neurotransmitters Half-life (T1/2) CYP450 enzyme Notes/Notable side effects/Precautions SSRIs Citalopram (Celexa) serotonin reuptake inhibitor (S-RI) Commonly Prescribed for Depression Premenstrual dysphoric disorder (PMDD) Obsessive-compulsive disorder (OCD) Panic disorder Generalized anxiety disorder (GAD) Posttraumatic stress ...

NR546 WEEK 5 KNOWLEDGE TEST. // EXAM STUDY GUIDE WITH VERIFIED ANSWERS. // 2024/2025 UPDATE. // NEW EXAM!!! NEW EXAM!!! Cyclothymia: - Ans-involves the chronic presentation of hypomanic and depressive symptoms that do not meet the diagnostic criteria for a major depressive or manic/hypomanic episode. If bipolar depression is mistaken for MDD: - Ans-antidepressant therapy may precipitate a manic episode or induce rapid-cycling bipolar depression -may contribute to the increased inc...

NR546 Midterm Exam Questions And Answers 2023 Update A+ What should the PMHNP consider when prescribing chemical restraints? - Answer-- allergy status -prior med hx for adverse drug reactions r/t the meds ordered in the chemical restraint -state regulations regarding chemical restrains must be reviewed Are the PMHNP and other staff liable if the client has an allergic reaction or adverse side effects to the drugs used for chemical restraint? - Answer-No. The client has been court-order...

NR546 week 7 test your knowledge quiz with Answers 1. Neurotransmitters involved in ADHD 2. Pharmacologic Treatment of Sleep Disorders: 3. prevalence of ADHD in the United States population Dopamine & norepinephrine -affect symptoms of inattention & hyperactivity Over-the-counter Melatonin Orexin receptor antagonists Antidepressants Z-drugs Benzodiaze

VERIFIED QUESTIONS AND ANSWERS FOR NR546 Pharmacologic Treatment of Major Depressive Disorder - CORRECT ANSWERSelective serotonin reuptake inhibitors (SSRIs) Serotonin-norepinephrine reuptake inhibitors (SNRIs) Norepinephrine and dopamine reuptake inhibitors (NDRIs) Serotonin antagonists and reuptake inhibitors (SARIs) Miscellaneous antidepressants Monoamine oxidase (MAO)-B inhibitors Adjunct: antipsychotics Pharmacologic Treatment of Bipolar Disorder - CORRECT ANSWER-Lithium Anticon...

NR546 Psychopharmacology Mid-Term Exam *Q&A* |Verified Study Set| Explain the primary action of SSRIs in treating depression. SSRIs increase serotonin levels by inhibiting its reuptake into the presynaptic neuron, leading to enhanced mood regulation. What is the most significant risk of long-term benzodiazepine use? Dependency and tolerance, which can lead to withdrawal symptoms and abuse. Which neurotransmitter is primarily involved in the treatment of ADHD with stimulant medicat...

NR546 FINAL EXAM REVIEWS Pharmacologic Treatment of Bipolar Disorder - CORRECT ANSWER-Lithium Anticonvulsants Second generation antipsychotics Unipolar depression - CORRECT ANSWER-major depressive disorder (MDD) one of the most common mental disorders -Approximately 7.1% of adults in the U.S. had episode in last year, prevalence highest (13.1%) among individuals aged 18-25 S/S -depressed mood -loss of interest or pleasure in daily activities -irritability -withdrawal -problems with...